Title:Volatile Oil Containing Plants as Phytopharmaceuticals to Treat Psoriasis:
A Review
Volume: 25
Issue: 3
Author(s): Priyanka J. Vyas, Shivani S. Wagh, Mohan G. Kalaskar, Kalpesh R. Patil, Ajay K. Sharma*, Imran Kazmi, Fahad A. Al-Abbasi, Sami I. Alzarea, Obaid Afzal, Abdulmalik S.A. Altamimi, Gaurav Gupta and Chandragouda R. Patil*
Affiliation:
- Department
of Pharmacognosy, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences & Research University, New
Delhi, 110017, India
- Department
of Pharmacognosy, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences & Research University, New
Delhi, 110017, India
Keywords:
Psoriasis, volatile oil, monoterpenes, sesquiterpenes, phenylpropanoids, pathogenesis.
Abstract:
Introduction: Psoriasis is a chronic skin condition caused by an autoimmune response
that accelerates the life cycle of skin cells, resulting in the characteristic symptoms of scaling,
inflammation, and itching.
Methods: Palliative treatment options for psoriasis often prioritize the use of volatile oils. These
oils contain monoterpenes, sesquiterpenes, and phenylpropanoids that are intricately linked to the
molecular cascades involved in the pathogenesis and symptoms of psoriasis. To evaluate the antipsoriatic
efficacy of volatile oils and their components, we conducted a systematic review of
scientific studies. Our literature search encompassed various online databases, including PubMed,
BIREME, SCIELO, Open Grey, Scopus, and ScienceDirect. The selected studies included experimental
in vitro/in vivo assessments as well as clinical studies that examined the potential of volatile
oils and their extracts as antipsoriatic agents. We excluded conference proceedings, case reports,
editorials, and abstracts. Ultimately, we identified and evaluated a total of 12 studies for
inclusion in our analysis.
Results: The data collected, compiled, and analyzed strongly support the interaction between volatile
oils and their constituents with the key molecular pathways involved in the pathogenesis of
psoriasis and the development of its symptoms. Volatile oils play a significant role in the palliative
treatment of psoriasis, while their chemical constituents have the potential to reduce the symptoms
and recurrence of this condition.
Conclusion: The current review highlights that the constituents found in volatile oils offer distinct
chemical frameworks that can be regarded as promising starting points for the exploration and
development of innovative antipsoriatic agents.